اینت علیاہ زاۊ کاریل ارسی فیک را ڪلہ انی سیرۈ ںار گلۇان
A woman has been awarded a $15,000 award by the state for an invention that helps patients who are at risk of being infected with Clostridium difficile, a bacterial infection that can cause severe complications including brain damage.
The doctor was awarded the award on Tuesday at the official launch of the government’s Clostidomics and Clostrosequencing Centre in Karachi.
Dr Aftab Aftakzai, a clinician at the centre, was diagnosed with Cliidomics at the age of 19.
He has since been diagnosed with the infection and underwent a series of tests to determine if he has it, but there has been no sign of the bacteria spreading.
Dr Aaftakzai is one of the country’s first researchers to study Clostri, which can cause mild and moderate symptoms that include fever, fatigue, chills and joint pain.
In his case, he has been prescribed a daily pill of Clostripid.
His condition has improved dramatically.
He has recovered from the initial symptoms of the infection, and his symptoms have eased.
The institute is currently conducting trials with patients with different conditions.
While Dr Aftackzai has not been given a patent on his invention, his work is still being developed by the government.
According to the award, the government will compensate Dr Aaftackzai up to $15 for every treatment that he delivers.
“I have to admit that I am extremely happy.
I am thankful for the government award.
The government has been very supportive.
This is what the country is about.
I think that they have been very responsive to my requests,” he told The Lad newspaper.
Dr Asghar said his work with ClioRed is a major milestone in the treatment of Cliadomics.
Cliidism, also known as Clostrio, is a bacterial illness that causes fever, nausea, and abdominal pain.
It is caused by a strain of bacteria that was originally discovered in the 1950s.
Since then, it has been associated with a number of severe illnesses, including pneumonia, brain infections and brain cancer.
Most of the patients in Pakistan suffer from the disease, but some have died.
As a result, the disease is considered treatable in most cases, but the majority of patients do not.
Because of this, there has not yet been any breakthrough in the diagnosis of Cliopidomics, a research initiative to develop a treatment for the disease.
Earlier this month, a team from the National Institute of Allergy and Infectious Diseases, or NIAID, revealed a cure for Cliopic syndrome, the second largest killer in the world.
This was the first time a cure had been reported from the country.
NIAID has also set up an initiative to find a vaccine.
However, the treatment is still a work in progress.
Ahead of the announcement, Dr Aafakzai said he was hopeful that a cure could be found.
Read more about Cliids and Cliopics: